title: Interventional therapy for coronary artery disease.
authors.affiliation: Pulmonary and Critical Care Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
authors.forename: Pinak B
authors.initials: PB
authors.lastname: Shah
authors.forename: Craig M
authors.initials: CM
authors.lastname: Lilly
mesh_terms: D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D017225:Atherectomy, Coronary / Q000379:methods; D001918:Brachytherapy; D006328:Cardiac Catheterization / Q000009:adverse effects; D002986:Clinical Trials as Topic; D017023:Coronary Angiography; D003327:Coronary Disease / Q000601:surgery / Q000628:therapy*; D023903:Coronary Restenosis / Q000532:radiotherapy; D003328:Coronary Thrombosis / Q000601:surgery; D003422:Critical Care; D005500:Follow-Up Studies; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D007362:Intensive Care Units; D008279:Magnetic Resonance Imaging; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D010976:Platelet Count; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D017713:Platelet Transfusion; D011182:Postoperative Care; D011183:Postoperative Complications / Q000628:therapy; D012008:Recurrence; D012106:Research; D012307:Risk Factors; D015607:Stents / Q000009:adverse effects / Q000639:trends; D017131:Thrombectomy / Q000379:methods; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D001241:Aspirin; D000077284:Abciximab